By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DSM Biologics 

6000, Royalmount Avenue

Montreal  Quebec  H4P 2T1  Canada
Phone: 514-341-9940 Fax: 514-341-7821


DSM Biologics, a business unit of DSM Pharmaceutical Products, is a leading provider of manufacturing technology & services to the biopharmaceutical industry. In addition to offering world-class biopharmaceutical manufacturing services, DSM Biologics has co-exclusive rights, along with Dutch biotech company Crucell N.V., to license the high-producing PER.C6® human cell line as a production platform for recombinant proteins and monoclonal antibodies. DSM Biologics' FDA-approved facility in Groningen, the Netherlands was established in 1986, and has a strong track record in using a broad range of cell lines (PER.C6®, CHO, hybridoma, etc.) in biopharmaceutical manufacturing, and has wide-range of experience using multiple manufacturing (batch, fed-batch and continuous perfusion) and purification techniques. The combination of the PER.C6 human cell line and DSM's manufacturing services provides companies with a turn-key biologic manufacturing solution reducing cost, risk and time to market.

For more information, please visit

U.S. Headquarters:

DSM Pharmaceutical Products
45 Waterview Blvd.
Parsippany, N.J. 07054-1298
Phone: 973-257-8011

Last Updated: 03-27-2006

Key Statistics

Ownership: Private

Web Site: DSM Biologics

Company News
DSM Biologics Expands its Innovative Biomanufacturing Technology Portfolio With the Introduction of the New Kremer Method™ 6/28/2011 7:41:47 AM
DSM Biologics Reports a New Record Achievement with DSM's Proprietary XD(R) Process Technology with a CHO Cell Line Producing an Fc-fusion Protein: 2/9/2011 7:49:53 AM
DSM Biologics and NKT Therapeutics Inc. Sign Contract for Lead Product Development and Manufacture 2/8/2011 8:05:42 AM
DSM Biologics Announces Milestone Advancement of Yield-Boosting XD(R) Technology for Biomanufacturing 5/5/2010 11:52:43 AM
DSM Biologics to Acquire Rhobust(TM) Technology from Upfront Chromatography 5/5/2010 8:54:10 AM
DSM Biologics Announces Entering an Agreement with the Australian Governments to Build and Operate a Biopharmaceutical Manufacturing Facility in Brisbane 5/3/2010 10:09:43 AM
DSM PTG Unveils Bionate(R) II PCU 10/21/2009 9:00:22 AM
DSM Biologics Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms 5/18/2009 10:41:32 AM
DSM Biologics And Crucell N.V. (CRXL)l Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins 2/10/2009 12:07:30 PM
DSM Biologics and Crucell N.V. (CRXL) Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins 2/10/2009 9:10:15 AM